Article
Quantification of lamivudine-resistant hepatitis B virus mutants by type-specific TaqMan minor groove binder probe assay in patients with chronic hepatitis B.
Annals of clinical biochemistry - 1 Jan 2008
Yoshida Shigeru, Hige Shuhei, Yoshida Miyuki, Yamashita Naoki, Fujisawa Shin-ichi, Sato Kaori, Kitamura Tadashiro, Nishimura Masaharu, Chuma Makoto, Asaka Masahiro, Chiba Hitoshi
Abstract excerpt
BACKGROUND: Lamivudine (LAM)-resistant hepatitis B virus (HBV) with mutations in the polymerase region frequently appears after long-term use of LAM. Several methods allowing detection of mutant strains (YIDD, YVDD) have been reported, but they have no quantitative characteristics. In this study,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
